medigraphic.com
SPANISH

Revista de Especialidades Médico-Quirúrgicas

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 1

<< Back Next >>

Rev Esp Med Quir 2012; 17 (1)

Comparative study of two haemostatic agents added with epinephrine in adenotonsillectomy

Hernández PSH, Ortiz RA, García GCM
Full text How to cite this article

Language: Spanish
References: 37
Page: 3-7
PDF size: 145.21 Kb.


Key words:

adenotonsillectomy, bismuth, subsalicylate, subgallate.

ABSTRACT

Objective: To compare the hemostatic effects of two substances derived from bismuth (subsalicylate and subgalate) with epinephrine in the surgery of the tonsils and adenoids.
Material and methods: We designed a prospective, longitudinal, controlled, randomized single-blind study of 45 male and female patients from 3 to 55 years old with surgical indication for tonsillectomy, adenoidectomy or adenotonsillectomy seen in Centro de Cirugia Ambulatoria, ISSSTE from August to December, 2009. Patients were divided randomly into 3 groups of 15 patients each one: group 1, which used a mixture of bismuth subsalicylate + epinephrine as topical hemostatic; group 2, which used a mixture of bismuth subgallate and epinephrine as topical hemostatic and group 3, which used sutures or electrocautery as hemostatic methods, all patient underwent outpatient surgery.
Results: We included 45 patients from 3 to 55 years old (average 9.8 years), of which 22 were women (48.8%) and 23 men (51.1%). Two patients (4.4%) underwent adenoidectomy; a patient (2.2%) underwent tonsillectomy and the 42 remaining underwent adenotonsillectomy. Average bleeding group was: group 1 (BSS) 85.40 mL; group 2 (BSG) 67.66 mL and control group 112.00 mL.
Conclusions: Significant difference among three study groups was observed (p = 0.045), which was identified among the group 2 (BSG) and control (p = 0.023). There was not statistically significant difference between group 1 (BSS) and group 2 (BSG) (p = 0.074). Bismuth subsalicylate and bismuth subgallate plus epinephrine showed similar hemostatic efficacy and safety in adenotonsillectomy performed.


REFERENCES

  1. Johnson BL, Elluru RG, Myer CM. Complications of adenotonsillectomy.

  2. Laryngoscope 2002;112:35-36.

  3. Windfuhr JP, Chen YS, Remmert S. Hemorrhage following

  4. tonsillectomy and adenoidectomy in 15,218 patients. Otolaryngol

  5. Head Neck Surg 2005;132(2):281-286.

  6. Hernández PS, García GC. Consideraciones sobre amigdalectomía

  7. y adenoidectomía. An Orl Mex 2006;51(4):183-

  8. Thorisdottir H, Ratnoff OD, Maniglia AJ. Activation of Hageman

  9. factor (factor XII) by bismuth subgallate, a hemostatic

  10. agent. J Lab Clin Med 1988;112:481-486.

  11. Montes de Oca RD, Ramírez MG, Hernández ML. Subsalicilato

  12. de bismuto como agente hemostático en la

  13. adenoamigdalectomía de estancia breve. An Orl Mex

  14. 1991;35(2):123-125.

  15. Maniglia AJ, Kushener H, Cozzi L. Adenotonsillectomy: a

  16. safe outpatient procedure. Arch Otolaryngol Head Neck

  17. Surg 1989;115:92-94.

  18. Callanan V, Curran AJ, Smyth DA, et al. The influence of

  19. bismuth subgallate and adrenaline paste upon operating

  20. time and operative blood loss in tonsillectomy. J Laryngol

  21. Otol 1995;109(3):206-208.

  22. Fenton JE, Blayney AW, O’Dwyer TP. Bismuth subgallate-its

  23. role in tonsillectomy. J Laryngol Otol 1995;109(3):203-205.

  24. Mora LT, Trujillo FJ, Mora SJ. Eficacia y seguridad de la

  25. aplicación de subgalato y subsalicilato de bismuto como

  26. agentes hemostáticos después de la extracción quirúrgica

  27. de terceros molares. Revista ADM 2003;LX(3):90-94.

  28. Johnson BL, Elluru RG, Myer CM. Complications of adenotonsillectomy. Laryngoscope 2002;112:35-36.

  29. Windfuhr JP, Chen YS, Remmert S. Hemorrhage following tonsillectomy and adenoidectomy in 15,218 patients. Otolaryngol Head Neck Surg 2005;132(2):281-286.

  30. Hernández PS, García GC. Consideraciones sobre amigdalectomía y adenoidectomía. An Orl Mex 2006;51(4):183- 191.

  31. Thorisdottir H, Ratnoff OD, Maniglia AJ. Activation of Hageman factor (factor XII) by bismuth subgallate, a hemostatic agent. J Lab Clin Med 1988;112:481-486.

  32. Montes de Oca RD, Ramírez MG, Hernández ML. Subsalicilato de bismuto como agente hemostático en la adenoamigdalectomía de estancia breve. An Orl Mex 1991;35(2):123-125.

  33. Maniglia AJ, Kushener H, Cozzi L. Adenotonsillectomy: a safe outpatient procedure. Arch Otolaryngol Head Neck Surg 1989;115:92-94.

  34. Callanan V, Curran AJ, Smyth DA, et al. The influence of bismuth subgallate and adrenaline paste upon operating time and operative blood loss in tonsillectomy. J Laryngol Otol 1995;109(3):206-208.

  35. Fenton JE, Blayney AW, O’Dwyer TP. Bismuth subgallate-its role in tonsillectomy. J Laryngol Otol 1995;109(3):203-205.

  36. Mora LT, Trujillo FJ, Mora SJ. Eficacia y seguridad de la aplicación de subgalato y subsalicilato de bismuto como agentes hemostáticos después de la extracción quirúrgica de terceros molares. Revista ADM 2003;LX(3):90-94.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Esp Med Quir. 2012;17